Q1 2026 Holdings
Filed 2026-05-15 | 33 holdings | $2.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $714.9M | 8,493,321 | 26.7% |
| Erasca Inc(ERAS) | COM | 29479A108 | $265.1M | 16,382,812 | 9.9% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $203.5M | 4,148,428 | 7.6% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $185.9M | 3,685,448 | 6.9% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $130.3M | 6,474,485 | 4.9% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $99.0M | 1,180,000 | 3.7% |
| Damora Therapeutics Inc(GLTO) | COM NEW | 36322Q206 | $93.3M | 3,603,595 | 3.5% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $87.6M | 10,346,926 | 3.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $77.0M | 2,000,000 | 2.9% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $75.9M | 3,882,709 | 2.8% |
| Savara Inc(SVRA) | COM | 805111101 | $75.0M | 13,740,375 | 2.8% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $67.7M | 1,726,331 | 2.5% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $54.7M | 4,319,765 | 2.0% |
| VOR Biopharma Inc(VOR) | COM NEW | 929033207 | $54.3M | 3,041,719 | 2.0% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $47.8M | 1,602,034 | 1.8% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $46.9M | 9,982,124 | 1.8% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $45.2M | 3,220,364 | 1.7% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $39.4M | 2,173,913 | 1.5% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $39.2M | 2,133,576 | 1.5% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $38.3M | 6,434,990 | 1.4% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $33.7M | 4,843,380 | 1.3% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $32.5M | 4,771,414 | 1.2% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $26.8M | 1,675,262 | 1.0% |
| Adlai Nortye LTD(ANL) | SPONSORED ADS | 00704R109 | $22.2M | 3,212,731 | 0.8% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $19.7M | 8,695,652 | 0.7% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $19.6M | 1,379,965 | 0.7% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $18.5M | 3,851,654 | 0.7% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $18.4M | 632,931 | 0.7% |
| Septerna Inc(SEPN) | COM | 81734D104 | $12.2M | 506,056 | 0.5% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $11.4M | 1,009,500 | 0.4% |
| Alto Neuroscience Inc(ANRO) | COM SHS | 02157Q109 | $11.2M | 500,000 | 0.4% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $10.4M | 1,609,569 | 0.4% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $1.4M | 330,525 | 0.1% |